Nakamoto Inc.
NAKA, NAKAW · Finance Services · 696.1M shares · +20%/yr ↑ shares · EDGAR filings ↗
Net buyback after stock comp: -$219K (gross $22K, SBC $241K)
Reference price $5.79 · est. market cap ~$4.0B — last insider purchase, 2026-05-28 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D45Nakamoto Inc — bitcoin-treasury firm (KindlyMD merger) with deep losses.
Strengths
- Cash/crypto balance (56th pct)
Risks
- Operating margin -108; net loss
- Bitcoin-price dependence; pre-scale operations
Notable findings
- Auditor changeRecent 8-K item 4.01 8-K ↗
- Exec changeRecent 8-K item 5.02 8-K ↗
- Net lossNet loss (net margin -2867.6%)
- Material weaknessRisks Related to Our Financial Condition, Indebtedness, and Capital Requirements ● We have identified a material weakness in our internal control over financial reporting and may identify additio
- Insider buyingInsider buying — 5 open-market buy(s) by 1 insider(s) (~$992,628, last 6mo) Form 4 ↗
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Operating margin
-10824.0%
Net margin
-2867.6%
Return on equity
-10.2%
Return on assets
-7.1%
Revenue growth (QoQ)
501.9%
Current ratio
1.0×
Tangible book value
$511M
Cash & investments
$58M
Stock comp / revenue
129.5%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-28 | Bailey David F | Buy | 48K | $5.59 |
| 2026-05-28 | Bailey David F | Buy | 7.1K | $5.79 |
| 2026-05-27 | Bailey David F | Buy | 26K | $5.33 |
| 2026-05-27 | Bailey David F | Buy | 79K | $4.68 |
| 2026-05-26 | Bailey David F | Buy | 32K | $5.58 |
| 2026-03-12 | Evans Tyler Matthew | Grant | 600K | — |
| 2026-02-20 | Bailey David F | Grant | 108.2M | — |
| 2026-02-20 | Evans Tyler Matthew | Grant | 17.8M | — |
| 2026-02-20 | Evans Tyler Matthew | Grant | 17.8M | — |
| 2025-12-16 | Gendron Teresa S | Grant | 2.6M | — |
| 2025-12-16 | Dalton John Merritt | Grant | 1.6M | — |
| 2025-09-22 | Evans Tyler Matthew | Grant | 602K | — |
| 2025-09-22 | YUSKO MARK W | Grant | 113K | — |
| 2025-09-22 | McNulty Perianne Boring | Grant | 113K | — |
| 2025-09-22 | Blackburn Charles Phillip | Grant | 113K | — |
| 2025-09-22 | Weiss Eric Stanton | Grant | 113K | — |
| 2025-09-22 | Barrera Jared | Grant | 6.4K | — |
| 2025-09-22 | Pickett Timothy | Grant | 38K | — |
| 2025-09-22 | Pickett Timothy | Grant | 26K | — |
| 2025-09-22 | Pickett Timothy | Grant | 10K | — |
| 2025-09-22 | Pickett Timothy | Grant | 18K | — |
| 2025-09-22 | Xethalis Gregory Elias | Grant | 113K | — |
| 2025-09-22 | Fabiano Amanda | Grant | 752K | — |
| 2025-09-22 | Fabiano Amanda | Grant | 3.4M | — |
| 2025-09-22 | Bailey David F | Grant | 752K | — |
| 2025-09-22 | Creighton Andrew John | Grant | 602K | — |
| 2025-08-14 | Evans Tyler Matthew | Grant | 2.2M | — |
| 2025-08-14 | Creighton Andrew John | Grant | 2.2M | — |
| 2025-08-14 | Bailey David F | Grant | 11.2M | — |
| 2025-05-12 | Seelhorst Gary | Grant | 1.8K | $1.61 |
| 2025-05-12 | Robinson Christian S. | Grant | 1.8K | $1.61 |
| 2025-05-12 | Powell Amy | Grant | 1.8K | $1.61 |
| 2025-05-12 | Pickett Timothy | Grant | 29K | $1.61 |
All non-derivative Form 4 activity (SEC), newest first.
Clinical trials
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT03179501 ↗ | NP001, Alzheimer's Disease, and Blood Markers of Inflammation Alzheimer Disease | PHASE1 | Terminated | 2018-07-31 |
Source: ClinicalTrials.gov (U.S. NIH) · active studies first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-22 | Auditor changeExhibits | filing ↗ |
| 2026-06-11 | Debt obligationReg FDOtherExhibits | filing ↗ |
| 2026-05-22 | 3.03Exec/director change5.03Reg FDExhibits | filing ↗ |
| 2026-05-13 | ResultsExhibits | filing ↗ |
| 2026-05-12 | Shareholder voteExhibits | filing ↗ |
| 2026-05-07 | Material agreementExec/director changeExhibits | filing ↗ |
| 2026-04-07 | Exhibits | filing ↗ |
| 2026-03-31 | ResultsExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-22 | 2026-06-17 | 0001493152-26-029606 ↗ |
| 8-K | 2026-06-11 | 2026-06-05 | 0001493152-26-028223 ↗ |
| 8-K | 2026-05-22 | 2026-05-21 | 0001493152-26-025015 ↗ |
| 8-K | 2026-05-13 | 2026-05-13 | 0001493152-26-022786 ↗ |
| 10-Q | 2026-05-13 | 2026-03-31 | 0001493152-26-022777 ↗ |
| 8-K | 2026-05-12 | 2026-05-08 | 0001493152-26-022494 ↗ |
| 8-K | 2026-05-07 | 2026-05-04 | 0001493152-26-021600 ↗ |
| 8-K/A | 2026-04-07 | 2026-02-26 | 0001493152-26-015426 ↗ |
| 8-K | 2026-03-31 | 2026-03-30 | 0001493152-26-013693 ↗ |
| 10-K | 2026-03-30 | 2025-12-31 | 0001493152-26-013601 ↗ |
| 8-K | 2026-02-26 | 2026-02-20 | 0001493152-26-008131 ↗ |
| 8-K | 2026-02-19 | 2026-02-18 | 0001493152-26-007414 ↗ |